Your browser doesn't support javascript.
loading
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
Ishida, Hiroyuki; Kato, Motohiro; Kudo, Kazuko; Taga, Takashi; Tomizawa, Daisuke; Miyamura, Takako; Goto, Hiroaki; Inagaki, Jiro; Koh, Katsuyoshi; Terui, Kiminori; Ogawa, Atsushi; Kawano, Yoshifumi; Inoue, Masami; Sawada, Akihisa; Kato, Koji; Atsuta, Yoshiko; Yamashita, Takuya; Adachi, Souichi.
Afiliação
  • Ishida H; Department of Pediatrics and Blood and Marrow Transplantation, Matsushita Memorial Hospital, Moriguchi, Japan; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: ishidah@koto.kpu-m.ac.jp.
  • Kato M; Department of Pediatrics and Cell Therapy and Transplantation Medicine, University of Tokyo, Tokyo, Japan.
  • Kudo K; Department of Pediatrics, Fujita Health University School of Medicine, Aichi, Japan.
  • Taga T; Department of Pediatrics, Shiga University, Graduate School of Medicine, Otsu, Japan.
  • Tomizawa D; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Miyamura T; Department of Pediatrics, Osaka University, Graduate School of Medicine, Suita, Japan.
  • Goto H; Devision of Hemato-Oncology/Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Inagaki J; Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan.
  • Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Terui K; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Ogawa A; Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
  • Kawano Y; Department of Pediatrics, Kagoshima University Medical and Dental Hospital, Kagoshima, Japan.
  • Inoue M; Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
  • Sawada A; Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
  • Kato K; Department of Hematology/Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation and Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yamashita T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center, Tokyo, Japan.
  • Adachi S; Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Biol Blood Marrow Transplant ; 21(12): 2141-2147, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26271192

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bussulfano / Leucemia Mieloide Aguda / Irradiação Corporal Total / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Agonistas Mieloablativos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bussulfano / Leucemia Mieloide Aguda / Irradiação Corporal Total / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Agonistas Mieloablativos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article